Of interest, RdB/IL12/shVEGF treatment resulted in lowest accumulation of immunosuppressive regulatory T cells (Treg; FoxP3-positive), suggesting that RdB/IL12/shVEGF can reverse tumor-induced immunosuppression to enhance intratumoral infiltration of immune cells. This evidence concerns the gene FOXP3 and neoplasm.